ELV240920C540000
- 8.59
- -2.91-25.30%
Elevance Health Newsroom
Elevance Health Hits 4-week Low
Elevance Health Price Target Maintained With a $600.00/Share by Cantor Fitzgerald
Humana, Alignment Stocks Are Dropping. What's Behind the Decline. -- Barrons.com
Carelon Behavioral Health Earns Call/Text/Chat Crisis Accreditation From International Council for Helplines
CVS, Humana Dip Amid New Mental Health Guidelines, Leerink Note
Elevance Health To Go Ex-Dividend On September 10th, 2024 With 1.63 USD Dividend Per Share
September 8th (Eastern Time) - $Elevance Health(ELV.US)$ is trading ex-dividend on September 10th, 2024.Shareholders of record on September 10th, 2024 will receive 1.63 USD dividend per share on
Elevance Health (NYSE:ELV) Might Have The Makings Of A Multi-Bagger
$100 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today
Looking Into Elevance Health's Recent Short Interest
13 Analysts Have This To Say About Elevance Health
Stephens & Co. Reiterates Overweight on Elevance Health, Maintains $615 Price Target
Elevance Health Analyst Ratings
Is Elevance Health Stock Outperforming the Nasdaq?
Stephens Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $615
Stephens analyst Scott Fidel maintains $Elevance Health(ELV.US)$ with a buy rating, and maintains the target price at $615.According to TipRanks data, the analyst has a success rate of 70.1% and a
【US Stock Market Review】Weak employment data and rising interest rate cuts, but Wall Street still remains low.
On Wednesday, September 4th, the US stock market trended lower. Data shows a further slowdown in the US labor market, strengthening Wall Street's bets on a Fed rate cut, leading to a sharp drop in US Treasury yields. The overall assessment of the Fed's Beige Book is not optimistic enough. Technology stocks are the largest weighted stocks in the market, and some larger companies in this industry have a huge impact on the large cap due to their massive market cap.
Centene's Medicaid Pressures Weigh on Stocks of Major Insurers
Elevance Health Stock Has More to Offer: Should You Hold on Tight?
Centene Stock Drops 8% Amid Lowered Medicaid Forecast
US stocks dig deep | The medical insurance sector outperformed the market against the trend, with UnitedHealth hitting a yearly high; Does the risk aversion sentiment boost high-dividend stocks? Verizon, Johnson & Johnson, and other stocks continued to ri
AT&T has signed an agreement with nokia oyj to build a fiber optic network, with the former's stock price reaching a new high in a year; vaxcyte's vaccine trial data has been successful, causing the stock price to soar by 36%; the drug research of French pharmaceutical company sanofi has been successful, leading to a gap up in the stock price and hitting a new high.
Wells Fargo Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $593
Wells Fargo analyst Steve Baxter maintains $Elevance Health(ELV.US)$ with a buy rating, and adjusts the target price from $600 to $593.According to TipRanks data, the analyst has a success rate of 57.